Headwaters Capital Management, an investment management company, released its fourth-quarter 2024 investor letter. A copy of ...
TransMedics is navigating macroeconomic challenges amid its focus on meaningful progress across each of its growth initiatives.
Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of ...
JP Morgan has recently reduced TransMedics Group Inc (TMDX) stock to Neutral rating, as announced on December 17, 2024, according to Finviz. Earlier, on November 22, 2024, Needham had reduced the ...
NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
TransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion Capital on Jan. 10, 2025, stating them as inaccurate and misleading.
**NM signifies a non meaningful value. A dash signifies the data is not available.